Evaluate Umbilical Cord-derived Allogeneic Mesenchymal Stem Cells for the Treatment of Bradykinesia
Clinical trial NCT04385056 · UNKNOWN
Trial details
- NCT number
- NCT04385056
- Sponsor
- IMAC Holdings, Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-15
- Primary completion
- 2022-07-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.